Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kai Kang & Yue Wang. (2019) Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway. Drug Design, Development and Therapy 13, pages 4451-4460.
Read now
Read now
Min Jin, Jun Cai, Xuan Wang, Tao Zhang & Yingchao Zhao. (2018) Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review. Cancer Biology & Therapy 19:12, pages 1088-1092.
Read now
Read now
Jin-min Xue, Manirakiza Astère, Mao-xi Zhong, Han Lin, Jin Shen & Yu-xi Zhu. (2018) Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis. OncoTargets and Therapy 11, pages 6119-6128.
Read now
Read now
Anji Li, Shuai Sun, Tao Song, Xi Li, Wen Cheng, Ruipin Yao, Danying Zhang, Zailong Cai, Jie Zhang, Dongxia Zhai & Chaoqin Yu. (2018) Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report. OncoTargets and Therapy 11, pages 3705-3711.
Read now
Read now
Articles from other publishers (10)
Hang-Ping Wei, Jie Mao & Zu-Liang Hu. (2022) Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report. World Journal of Clinical Cases 10:11, pages 3593-3600.
Crossref
Crossref
Zhongyu Wang, Yake Huang, Ling Long, Li Zhou, Yan Huang, Lei Gan, Aimin Pu, Sufen Li & Rongkai Xie. (2021) Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression. Journal of Ovarian Research 14:1.
Crossref
Crossref
Xiaodan Sun, Ji Li, Yizhuo Li, Shouhan Wang & Qingchang Li. (2020) Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
Crossref
Lihua Chen, Xi Cheng, Wenzhi Tu, Zihao Qi, Haoran Li, Fei Liu, Yufei Yang, Zhe Zhang & Ziliang Wang. (2019) Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells. Cellular Oncology 42:5, pages 679-690.
Crossref
Crossref
Jing Tang, Xu Yong Li, Jing Bo Liang, De Wu, Li Peng & Xiaobing Li. (2019) Apatinib Plus Chemotherapy Shows Clinical Activity in Advanced NSCLC: A Retrospective Study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27:6, pages 635-641.
Crossref
Crossref
Zedong Du, Yanxin Yu, Dajun Wu, Guangyu Zhang, Yang Wang, Liang He & RongQin Meng. (2018) Apatinib for salvage treatment of advanced malignant pleural mesothelioma. Medicine 97:45, pages e13105.
Crossref
Crossref
Xiaofeng Li, Yueming He, Jinfeng Zhu, Hongxia Pang, Yongwei Lin & Jinyang Zheng. (2018) Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review. Oncotarget 9:72, pages 33734-33738.
Crossref
Crossref
Huiting Sun, Min Xiao, Sufen Liu & Ruxia Shi. (2018) Use of apatinib combined with pemetrexed for advanced ovarian cancer. Medicine 97:27, pages e11036.
Crossref
Crossref
Xiaoyun Liu, Yifan Zhang, Qian Chen, Yan Zhan, Quanren Wang, Chaoying Hu, Chen Yu, Zitao Guo, Xiaoyan Chen & Dafang Zhong. (2017) Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole. The Journal of Clinical Pharmacology 58:3, pages 347-356.
Crossref
Crossref
. (2017) Apatinib. Reactions Weekly 1648:1, pages 46-46.
Crossref
Crossref